Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Andresen, , Helene,
DOB:	17-OCT-1939 (Age: 86)
Gender:	female
Address:	Kristiansenberget 2 0172 Sørensen (Norway)
ID:	3450-170343-2 (ECI)

Report
Date:	30-NOV-2024

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Oslo universitetssykehus (Ullevål) 0155 Oslo (Norway)

Specimen
Collected:	30-NOV-2024

Chemistry

Test	30-NOV-2024	Reference Range	Unit
Glucose [Mass/volume] in Blood	86.2	70 - 140	mg/dL
Urea nitrogen [Mass/volume] in Blood	15.0	7 - 25	mg/dL
Creatinine [Mass/volume] in Blood	2.7 H	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	8.6	8.6 - 10.4	mg/dL
Sodium [Moles/volume] in Blood	142.2	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.0	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	106.8	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	20.6 L	22 - 32	mmol/L
Protein [Mass/volume] in Serum or Plasma	6.7	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.0	3.5 - 5.5	g/dL
Globulin [Mass/volume] in Serum by calculation	2.2	2.2 - 3.7	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.3	0.3 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	44.6	40 - 130	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	43.4	7 - 55	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	15.6	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	204.8 H	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	151.8	10 - 175	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	100.8	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	32.2 L	50 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows elevated creatinine, suggesting impaired renal function, and low total CO₂, which may indicate mild metabolic acidosis. Cholesterol is slightly elevated with low HDL, increasing cardiovascular risk. Other parameters, including glucose, electrolytes, liver enzymes, and proteins, are within normal limits. Renal function and cardiovascular risk factors should be further evaluated.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows elevated creatinine, suggesting impaired renal function, and low total CO₂, which may indicate mild metabolic acidosis. Cholesterol is slightly elevated with low HDL, increasing cardiovascular risk. Other parameters, including glucose, electrolytes, liver enzymes, and proteins, are within normal limits. Renal function and cardiovascular risk factors should be further evaluated.